Efficacy of imidazolquinoline on treatment of condyloma acuminatum of the buccal mucosa

• Published in: Special care in dentistry 2017-01, Vol.37 (1), p.51-54
• Main Authors: Curi, Davi Silva Carvalho, Leite‐Ribeiro, Patrícia Miranda, Torregrossa, Vinicius Rabelo, Vieira, Vinicius Costa, Sarmento, Viviane Almeida
• Format: Article
• Language: English
• Subjects: Adult; Aminoquinolines - therapeutic use; Anogenital; Anti-HIV Agents - therapeutic use; Antiretroviral drugs; Buccal mucosa; Condyloma acuminatum; Condylomata Acuminata - drug therapy; Cryotherapy; Dentistry; HIV; HIV Infections - drug therapy; Human immunodeficiency virus; Humans; Imidazolquinoline; Immunomodulation; Male; Mouth Mucosa - drug effects; Mouth Mucosa - virology; Neoplasia; Oral cavity; Sexually transmitted diseases; STD; Warts
• ISSN: 0275-1879; 1754-4505
• DOI: 10.1111/scd.12199

ABSTRACT The condylomata acuminata is a benign epithelial neoplasm induced by papillomavirus, and it is characterized by the proliferation of stratified squamous epithelial tissue that affects the anogenital and oral mucosa. It is considered to be a sexually transmitted disease and has a higher prevalence in individuals infected with human immunodeficiency virus. Various therapies have been used for the removal of lesions, such as cryotherapy, surgical laser and surgical excision, which are painful and scarring. These techniques, however, do not eliminate the virus and relapses are common shortly after treatment. The use of immunomodulators has been proposed to be an alternative treatment, as imidazolquinoline has been shown to be effective in the treatment of lesions in the anogenital region. However, its use in the oral cavity has been the subject of few reports in the literature. Thus, the objective of this study is to describe a case of warts in the labial mucosa of an HIV positive patient using imidazolquinoline 5%.